Nektar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	35.28	88.23	25.22	198.96	96.36	194.91	4.76	59.64	55.57	37.37	Upgrade
Short-Term Investments	268.34	416.75	708.74	862.94	1,228	1,140	291.37	329.46	253.37	225.46	Upgrade
Cash & Cash Equivalents	303.62	504.98	733.96	1,062	1,325	1,335	296.13	389.1	308.94	262.82	Upgrade
Cash Growth	-39.88%	-31.20%	-30.88%	-19.85%	-0.79%	350.93%	-23.89%	25.95%	17.55%	0.30%	Upgrade
Receivables	1.21	5.98	22.49	38.89	36.8	43.21	5.01	15.68	19.95	3.61	Upgrade
Inventory	16.1	19.2	15.8	15.29	12.67	11.38	10.73	11.11	11.35	12.95	Upgrade
Other Current Assets	9.78	15.81	23.33	21.93	47.22	47.74	14.95	10.06	9.81	8.82	Upgrade
Total Current Assets	330.7	545.97	795.58	1,138	1,422	1,438	326.82	425.95	350.05	288.2	Upgrade
Property, Plant & Equipment	36.86	85.89	177.54	186.14	199.84	48.85	47.46	65.6	71.34	70.37	Upgrade
Long-Term Investments	25.83	0	64.83	136.66	279.12	582.89	57.09	0	0	0	Upgrade
Goodwill and Intangibles	0	76.5	76.5	76.5	76.5	76.5	76.5	76.5	76.5	76.5	Upgrade
Other Long-Term Assets	4.64	2.25	2.74	1.46	0.34	4.24	0.99	0.82	0.75	6.55	Upgrade
Total Long-Term Assets	67.33	164.63	321.61	400.76	555.81	712.49	182.05	142.92	148.59	153.42	Upgrade
Total Assets	398.03	710.6	1,117	1,539	1,977	2,150	508.87	568.87	498.64	441.62	Upgrade
Accounts Payable	9.85	12.98	9.75	22.14	19.23	5.85	4.78	2.82	2.36	2.7	Upgrade
Deferred Revenue	0	0	0	0	8.07	24.64	37.97	66.24	83.85	101.38	Upgrade
Current Debt	19.26	18.67	17.44	13.92	265.41	0	0	0	4.76	4.51	Upgrade
Other Current Liabilities	22.16	36.56	58.01	79.73	61.18	51.51	13.41	3.17	-29.73	-44.55	Upgrade
Total Current Liabilities	51.27	68.2	85.2	115.78	353.89	82	56.16	72.22	61.25	64.05	Upgrade
Long-Term Debt	98.52	112.83	125.74	136.37	142.73	246.95	245.21	243.46	242.77	129.14	Upgrade
Other Long-Term Liabilities	117.26	162.93	226.75	209.32	75.34	103.65	119.67	165.06	188.2	212.1	Upgrade
Total Long-Term Liabilities	215.78	275.76	352.48	345.69	218.07	350.6	364.88	408.52	430.97	341.24	Upgrade
Total Liabilities	267.05	343.96	437.68	461.47	571.97	432.6	421.04	480.75	492.21	405.29	Upgrade
Total Debt	117.78	131.5	143.18	150.29	408.14	246.95	245.21	243.46	247.53	133.65	Upgrade
Debt Growth	-10.43%	-8.16%	-4.73%	-63.18%	65.27%	0.71%	0.72%	-1.64%	85.20%	-2.15%	Upgrade
Retained Earnings	-3,477.25	-3,201.19	-2,833	-2,309.16	-1,864.72	-1,424.05	-2,117.94	-2,021.01	-1,867.49	-1,786.31	Upgrade
Comprehensive Income	0.08	-6.91	-4.16	-2.3	-1.01	-6.32	-2.11	-2.36	-2.17	-1.57	Upgrade
Shareholders' Equity	130.99	366.64	679.51	1,077	1,405	1,718	87.83	88.13	6.43	36.33	Upgrade
Net Cash / Debt	185.84	373.48	590.78	911.61	916.73	1,088	50.93	145.64	61.42	129.17	Upgrade
Net Cash / Debt Growth	-50.24%	-36.78%	-35.19%	-0.56%	-15.77%	2037.26%	-65.03%	137.13%	-52.45%	2.98%	Upgrade
Net Cash Per Share	0.98	2.00	3.22	5.10	5.24	6.04	0.33	1.04	0.46	1.02	Upgrade
Working Capital	279.43	477.76	710.38	1,022	1,068	1,356	270.66	353.73	288.81	224.15	Upgrade
Book Value Per Share	0.69	1.96	3.71	6.03	8.03	10.13	0.56	0.63	0.05	0.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).